CMS Open Payments · Program Year 2024
Expanding Innovations, Inc.
Expanding Innovations, Inc. reported $566,453.50 across General Payments, Research, and Ownership to 92 physicians and teaching hospitals across 114 transactions.
- $566.5K Above-median payer
- All-tracks total
- 114 Below-median volume
- Transactions
- 92 Below-median reach
- Recipients
- −$8.9K
- General Payments vs PY2023
Expanding Innovations, Inc. reported $566,453.50 across all CMS Open Payments tracks (General + Research + Ownership) to 92 physicians and teaching hospitals in Program Year 2024 - ranking #735 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $130,765.00, averaging $6.2K per recipient.
How Expanding Innovations, Inc.'s $566.5K all-tracks total breaks down
Expanding Innovations, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
22/100
Total payments
F
15/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer expanding-innovations-inc Expanding Innovations, Inc.
$566.5K · #735/1,925 · 0.0% industry · PY2024
- TOT $566.5K
- RANK #735
- SHARE 0.0%
- TXN 114
- RCP 92
- CAT 4
- GEN $130.8K
- ΔGEN −$8.9K
- TOP1 11.3%
- PY 2024
Volume peers
Nearest volume peer: Republic Spine ($567.3K)
Expanding Innovations, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Expanding Innovations, Inc.'s CMS-reported General Payments decreased by $8.9K (−6.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: EXPANDING INNOVATIONS, INC.PY2023: EXPANDING INNOVATIONS, INC.PY2024: Expanding Innovations, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $139,632.10
- PY2024
- $130,765.00
What the Data Shows for Expanding Innovations, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Expanding Innovations, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $72.5K, accounting for 55.4% of this company's General Payments and 41 transactions.
General Payment Breakdown by Type
Across 4 types of general payments, Expanding Innovations, Inc.'s largest category was "Consulting Fee" at $72.5K - 55.4% of General Payments.
Expanding Innovations, Inc. reports 4 general-payment categories - the top three are Consulting Fee (55.4%), Royalty or License (42.3%), and Food and Beverage (1.5%). The remaining 1 category make up 0.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Expanding Innovations, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $72.5K | 41 | 55.4% |
| Royalty or License | $55.3K | 23 | 42.3% |
| Food and Beverage | $1.9K | 27 | 1.5% |
| Travel and Lodging | $1.2K | 1 | 0.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $56,159.00 (42.9%) of $130,765.00 in this company's General Payments records across 42 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Expanding Innovations, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Kenneth Brandon Strenge
$14,725.00 across 6 reported transactions
- 2
Frank La Marca
$11,529.00 across 6 reported transactions
- 3
Wilson Zachary Ray
$11,404.00 across 8 reported transactions
- 4
Jeffrey Gum
$9,424.00 across 3 reported transactions
- 5
Marc Levine
$9,077.00 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Expanding Innovations, Inc. ranks #735 of 1,925 by total payments (top 38% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,199 of 1,838 by HHI (bottom 35% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Medartis Inc. : $1.0M total payments, HHI 655
- KARL STORZ Endoscopy-America : $1.4M total payments, HHI 655
- Advanced Critical Devices, Inc. : $1.2K total payments, HHI 653
- BioLineRx USA, Inc. : $112.3K total payments, HHI 652
- Cardinal Health 108 LLC : $1.8K total payments, HHI 651
- ADMA BioManufacturing LLC : $167.7K total payments, HHI 650
- Expanding Innovations, Inc. (this company) : $130.8K total payments, HHI 649
- US Implant Solutions, LLC : $157.1K total payments, HHI 646
- Edap Technomed Inc : $640.3K total payments, HHI 644
- PENTAX of America, Inc. : $368.9K total payments, HHI 642
- Bone Support Inc. : $613.3K total payments, HHI 641
- Eagle Pharmaceuticals, Inc. : $177.1K total payments, HHI 640
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Expanding Innovations, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Expanding Innovations, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Expanding Innovations, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
CTL Medical Corporation
Perfuze Limited
Hyperfine Operations, Inc.
Maxx Orthopedics, Inc.
Zest Holdings, LLC
Put this to use
Expanding Innovations, Inc. ranks #735 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Expanding Innovations, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.